Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Dysstasia, X-ray
Clinical narrative: After the 2nd shot, my right knee has continual pain and weakness, which makes it difficult to stand up after sitting, especially after using the toilet.; After the 2nd shot, my right knee has continual pain and weakness, which makes it difficult to stand up after sitting, especially after using the toilet.; After the 2nd shot, my right knee has continual pain and weakness, which makes it difficult to stand up after sitting, especially after using the toilet.; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 56-year-old non pregnant female patient received (not pregnant at the time of vaccination) second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection, Batch/Lot Number: EN6208), dose 2 via an unspecified route of administration, administered in arm left on 26Mar2021 16:00 (at the age of 56-year-old) as dose 2, single for COVID-19 immunization. Medical history included osteoarthritis from an unknown date and unknown if ongoing, atrial fibrillation from an unknown date and unknown if ongoing, enlarged thyroid with goitre from an unknown date and unknown if ongoing and goitre from an unknown date and unknown if ongoing. Concomitant medication(s) (taken within two weeks of vaccination) included bisoprolol fumarate, hydrochlorothiazide (BISPROLOL COMP) taken for an unspecified indication, start and stop date were not reported; vitamin d nos (VITAMIN D NOS) taken for an unspecified indication, start and stop date were not reported; cyanocobalamin (B-12) taken for an unspecified indication, start and stop date were not reported; aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]) taken for an unspecified indication, start and stop date were not reported. The patient had a known allergy to sulfa, cephzil and Macrobid. The patient did not receive any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection, Batch/Lot Number: EL6198), dose 1 via an unspecified route of administration, administered in left arm on 09Mar2021 4:00 PM as dose 1, single for COVID-19 immunization and experienced leg cramps. On an unspecified date in 2021, after the 2nd shot, her right knee has continual pain and weakness, which makes it difficult to stand up after sitting, especially after using the toilet. The patient went to her primary care provider for the pain, they ordered an x-ray, which came back normal, but she continued to have the pain and weakness. The patient received treatment for the events and her doctor suggested for X-ray, ice and exercise. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included x-ray: normal on an unspecified date. The outcome of the event was not recovered at the time of the report.  Follow-up attempts are completed. No further information is expected.